Relapse of acute leukemia following hematopoietic stem cell transplantation (HSCT) usually
represents return of an original disease clone, having evaded eradication by pretransplant …

ALTHOUGH MANY ASPECTS of the development of malignant tumors are still incompletely
understood, conditions have been identified under which malignancies develop at a higher …

In a prospective study of 613 patients with cirrhosis of different aetiological types increasing
age, male sex, and non-UK nationality were found to be significant independent risk factors …

Donor cell leukemia (DCL) is a rare complication of hematopoietic cell transplantation
(HCT). Its incidence has been reported between 0.12% and 5%, although the majority of …

Although mast cells are hematopoietic cells, little is known about the origin of their
precursors in vivo. In this study, the origin (donor v recipient genotype) of human mast cells …

Abstract 30 patients with homozygous β-thalassaemia aged 6 months to 7 years received
allogeneic marrow transplants following busulphan (Bu) and cyclophosphamide (Cy). Post …

A multi‐centre retrospective analysis on 117 patients relapsing after bone marrow
transplantation (BMT) for acute leukaemia was carried out by the Leukaemia Working Party …

Increasing the upper age limit for recipients of hematopoietic stem cell transplantation (HCT)
naturally has also increased the age of the corresponding related donor population …

Clonal hematopoiesis of indeterminate potential (CHIP) is a common age-related condition
affecting over 10% of healthy adults older than age 65 years. Its prevalence gradually …

Organ and tissue transplant is now the treatment of choice for many end stage diseases. In
the recent years, there has been an increasing demand for organs but not a similar increase …